Press release
Tetanus Toxoid Vaccine Market Projected to Reach $ 5.5 billion at 5.3% CAGR Till 2023 | Global Key Players – GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech.
Market Research Future has announced the addition of the "Global Tetanus Toxoid Vaccine Market Research Report which gives Market Size, Shares and Forecasts till 2023. The Tetanus Toxoid Vaccine Industry Report Provide analysis and evaluation of the current and prospective profitability.Global Tetanus Toxoid Vaccine Market -Scenario
Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone fractures. Other symptoms include fever, sweating, headache, trouble swallowing, hypertension etc. About 10% of those infected, die while a large number become incapacitated due to bone fractures.
Request Sample with New Technological Trends @ https://www.marketresearchfuture.com/sample_request/4024
Tetanus toxoid vaccine is an inactive vaccine used to prevent tetanus by developing immunity against the pathogen causing tetanus. The general dosage recommendation is five doses during childhood, with a sixth given during adolescence with additional doses every 10 years.
The tetanus vaccine was initially developed in 1924 and has resulted in a 95% decrease in the rate of tetanus in the US and is on the World Health Organization's List of Essential Medicines. The vaccine also is considered very safe even during pregnancy and for those with HIV.
Global Tetanus Toxoid Vaccine Market -Key players
Key players profiled in the report are
GlaxoSmithKline Plc.,
Merck & Co. Inc.,
Pfizer, Inc.,
Sanofi Pasteur, Inc.,
AstraZeneca Plc.,
Bharat Biotech,
Shenzhen Kangtai Biological Products,
Valeant Pharmaceuticals,
Emergent Biosolutions Inc.,
Astellas Pharma Inc.,
Panacea Biotec
Considering all these factors, the market for Tetanus toxoid vaccine is expected to reach $ 5.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.3 % during 2017-2023.
Global Tetanus Toxoid Vaccine Market -Segments
The global tetanus toxoid vaccine market is segmented on the basis of types, forms and end users. Based on types, the market has been segmented as monovalent tetanus toxoid (TT), diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (Tdap) and others.
Based on the forms, the market has been segmented as quadrivalent, pentavalent, and hexavalent. Based on the end users, the market has been segmented as biotech and hospitals and clinics, government organizations, research and others.
Access Report Details with TOC @ https://www.marketresearchfuture.com/reports/tetanus-toxoid-vaccine-market-4024
Global Tetanus Toxoid Vaccine Market -Regional analysis
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global Tetanus toxoid vaccine. Europe is the second largest market due to large disposable income and rising awareness.
Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
Global Tetanus Toxoid Vaccine -Major Points from TOC
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Tetanus Toxoid Vaccine Market, By Type
Chapter 7. Global Tetanus Toxoid Vaccine Market, By Treatment
Chapter 8 Global Tetanus Toxoid Vaccine Market, By End User
Chapter 9. Global Tetanus Toxoid Vaccine Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/4024
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tetanus Toxoid Vaccine Market Projected to Reach $ 5.5 billion at 5.3% CAGR Till 2023 | Global Key Players – GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech. here
News-ID: 1187961 • Views: …
More Releases from Market Research Future
Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics: Advancing Eye Care Through Targeted Treatment
Ophthalmic topical therapeutics have become a cornerstone in modern eye care, offering precise, localized treatment for a wide range of ocular conditions. Unlike systemic medications, which circulate throughout the body and may produce unintended side effects, topical therapies deliver active compounds directly to the eye, ensuring higher efficacy and a faster onset of action. This localized approach not only improves treatment outcomes…
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps: Transforming the Way We Care for Our Minds
In recent years, mental health has gained increasing recognition as an essential component of overall well-being. Despite growing awareness, many individuals still face barriers to accessing mental health support, including stigma, cost, and geographic limitations. Mental health apps have emerged as a transformative solution, leveraging technology to provide accessible, personalized, and convenient mental health care for millions worldwide.
The Rise of…
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves: A Critical Component of Modern Healthcare
Surgical gloves have become an indispensable element in modern healthcare, serving as a first line of defense against contamination, infection, and disease transmission. These gloves are not just protective gear-they are a symbol of safety, hygiene, and precision in medical practice. Their significance spans from routine hospital procedures to complex surgical interventions, highlighting their essential role in patient care and medical safety protocols.
The…
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market: Driving Innovation and Transformation in the Clinical Research Landscape
The Asia Pacific Contract Research Organization (CRO) market has been witnessing significant growth over the past decade, emerging as a pivotal hub for clinical research and drug development. With a growing population, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure, the region has become an attractive destination for pharmaceutical and biotechnology companies seeking cost-effective and…
More Releases for Tetanus
Tetanus Market Value Projected to Expand by 2029
Tetanus Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 21.36% from 2024 to 2030. Welcome to our comprehensive exploration of the Tetanus market, where we uncover the trends, innovations, and dynamics shaping the landscape of tetanus prevention and treatment. Tetanus, a potentially life-threatening bacterial infection, continues to pose challenges globally, driving the demand for effective preventive…
Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ".
The Global market size of Diphtheria, Pertussis,…
Tetanus Therapeutics- Pipeline Analysis 2018 | Zydus Group
Tetanus, also known as lockjaw is a bacterial disease caused by Clostridium tetani. The bacteria are usually found in dust, soil, and manure and enter the body through breaks in the skin. The spores develop into bacteria when they enter the body.
Download the sample report @ https://www.pharmaproff.com/request-sample/1074
These spores can get into the body through broken skin, usually through injuries from contaminated objects. Certain breaks in the skin are more…
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various…
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various…
Tetanus - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Tetanus - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Pipeline Review, H1 2017, provides an overview of the Tetanus (Infectious Disease) pipeline landscape.
Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles,…
